Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCUL

Ocular Therapeutix Inc

Jun 18 • 04:00PM ET

9.43

-0.21 -2.18 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM VKTX KRYS ALNY INCY KROS AXSM MDGL NBIX

| Held by: VTI IWM VXF IWO PJP VTWO SCHA XPH DFAS DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	8.42%	Shs Outstand	218.90M	Perf Week	8.39%
Market Cap	2.06B	Forward P/E	-	EPS next Y	-1.43	Insider Trans	-0.97%	Shs Float	200.52M	Perf Month	18.02%
Enterprise Value	1.48B	PEG	-	EPS next Q	-0.40	Inst Own	89.17%	Short Float	12.51%	Perf Quarter	14.03%
Income	-290.50M	P/S	39.68	EPS this Y	-12.45%	Inst Trans	0.51%	Short Ratio	8.20	Perf Half Y	-34.47%
Sales	52.04M	P/B	3.55	EPS next Y	10.22%	ROA	-51.03%	Short Interest	25.09M	Perf YTD	-22.32%
Book/sh	2.66	P/C	3.10	EPS next 5Y	7.37%	ROE	-68.55%	52W High	16.44 -42.64%	Perf Year	13.21%
Cash/sh	3.04	P/FCF	-	EPS past 3/5Y	-15.40% 11.13%	ROIC	-44.16%	52W Low	6.23 51.36%	Perf 3Y	96.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.29% 24.45%	Gross Margin	87.24%	Volatility	7.70% 5.85%	Perf 5Y	-30.20%
Dividend TTM	-	EV/Sales	28.39	EPS Y/Y TTM	-26.75%	Oper. Margin	-575.42%	ATR (14)	0.54	Perf 10Y	74.63%
Dividend Ex-Date	-	Quick Ratio	14.73	Sales Y/Y TTM	-12.76%	Profit Margin	-558.24%	RSI (14)	58.57	Recom	1.09
Dividend Gr. 3/5Y	- -	Current Ratio	14.81	EPS Q/Q	-4.58%	SMA20	8.33%	Beta	0.88	Target Price	26.91
Payout	-	Debt/Eq	0.14	Sales Q/Q	0.81%	SMA50	4.53%	Rel Volume	2.00	Prev Close	9.64
Employees	325	LT Debt/Eq	0.13	Earnings	May 05 BMO	SMA200	-10.31%	Avg Volume	3.06M	Price	9.43
IPO	Jul 25, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-27.06% -15.23%	Trades		Volume	6,112,006	Change	-2.18%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)